Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women’s Health Across the Nation

Vicki Hart, Susan R. Sturgeon, Nicholas Reich, Lynnette Leidy Sievert, Sybil L. Crawford, Ellen B Gold, Nancy E. Avis, Katherine W. Reeves

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: Two case–control studies reported a 50 % decreased breast cancer risk among women who experienced menopausal vasomotor symptoms (VMS), but one cohort study found no association. VMS may be triggered by declining estrogen levels during menopause, whereas elevated estrogen levels have been associated with increased breast cancer risk. VMS may thus be indicative of lower susceptibility to breast cancer. Methods: We evaluated this relationship in the longitudinal Study of Women’s Health Across the Nation (SWAN), using discrete survival analysis of approximately annual data on VMS and self-reported breast cancer occurrences for up to 13 years of follow-up in 3,098 women who were pre- or early perimenopausal at enrollment. Results: Over an average 11.4 years of follow-up, 129 incident breast cancer cases were self-reported, and approximately 50 % of participants experienced VMS. Symptomatic women had a reduced risk of breast cancer compared to non-symptomatic women (adjusted HR 0.63, 95 % CI 0.39, 1.00). The association was stronger in the subgroup of women who fully transitioned to postmenopause during follow-up (n = 67 cases, adjusted HR 0.45, 95 % CI 0.26, 0.77). Conclusion: VMS appeared to be a marker of reduced breast cancer risk. Future research is needed to understand the biology underlying this relationship.

Original languageEnglish (US)
Pages (from-to)1333-1340
Number of pages8
JournalCancer Causes and Control
Volume27
Issue number11
DOIs
StatePublished - Nov 1 2016

Fingerprint

Women's Health
Breast Neoplasms
Estrogens
Postmenopause
Survival Analysis
Menopause
Longitudinal Studies
Cohort Studies

Keywords

  • Breast cancer
  • Menopause
  • Postmenopausal
  • Vasomotor symptoms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women’s Health Across the Nation. / Hart, Vicki; Sturgeon, Susan R.; Reich, Nicholas; Sievert, Lynnette Leidy; Crawford, Sybil L.; Gold, Ellen B; Avis, Nancy E.; Reeves, Katherine W.

In: Cancer Causes and Control, Vol. 27, No. 11, 01.11.2016, p. 1333-1340.

Research output: Contribution to journalArticle

Hart, V, Sturgeon, SR, Reich, N, Sievert, LL, Crawford, SL, Gold, EB, Avis, NE & Reeves, KW 2016, 'Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women’s Health Across the Nation', Cancer Causes and Control, vol. 27, no. 11, pp. 1333-1340. https://doi.org/10.1007/s10552-016-0811-9
Hart, Vicki ; Sturgeon, Susan R. ; Reich, Nicholas ; Sievert, Lynnette Leidy ; Crawford, Sybil L. ; Gold, Ellen B ; Avis, Nancy E. ; Reeves, Katherine W. / Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women’s Health Across the Nation. In: Cancer Causes and Control. 2016 ; Vol. 27, No. 11. pp. 1333-1340.
@article{1c8fc166b1a54d0991c56648f31116e8,
title = "Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women’s Health Across the Nation",
abstract = "Purpose: Two case–control studies reported a 50 {\%} decreased breast cancer risk among women who experienced menopausal vasomotor symptoms (VMS), but one cohort study found no association. VMS may be triggered by declining estrogen levels during menopause, whereas elevated estrogen levels have been associated with increased breast cancer risk. VMS may thus be indicative of lower susceptibility to breast cancer. Methods: We evaluated this relationship in the longitudinal Study of Women’s Health Across the Nation (SWAN), using discrete survival analysis of approximately annual data on VMS and self-reported breast cancer occurrences for up to 13 years of follow-up in 3,098 women who were pre- or early perimenopausal at enrollment. Results: Over an average 11.4 years of follow-up, 129 incident breast cancer cases were self-reported, and approximately 50 {\%} of participants experienced VMS. Symptomatic women had a reduced risk of breast cancer compared to non-symptomatic women (adjusted HR 0.63, 95 {\%} CI 0.39, 1.00). The association was stronger in the subgroup of women who fully transitioned to postmenopause during follow-up (n = 67 cases, adjusted HR 0.45, 95 {\%} CI 0.26, 0.77). Conclusion: VMS appeared to be a marker of reduced breast cancer risk. Future research is needed to understand the biology underlying this relationship.",
keywords = "Breast cancer, Menopause, Postmenopausal, Vasomotor symptoms",
author = "Vicki Hart and Sturgeon, {Susan R.} and Nicholas Reich and Sievert, {Lynnette Leidy} and Crawford, {Sybil L.} and Gold, {Ellen B} and Avis, {Nancy E.} and Reeves, {Katherine W.}",
year = "2016",
month = "11",
day = "1",
doi = "10.1007/s10552-016-0811-9",
language = "English (US)",
volume = "27",
pages = "1333--1340",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "11",

}

TY - JOUR

T1 - Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women’s Health Across the Nation

AU - Hart, Vicki

AU - Sturgeon, Susan R.

AU - Reich, Nicholas

AU - Sievert, Lynnette Leidy

AU - Crawford, Sybil L.

AU - Gold, Ellen B

AU - Avis, Nancy E.

AU - Reeves, Katherine W.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Purpose: Two case–control studies reported a 50 % decreased breast cancer risk among women who experienced menopausal vasomotor symptoms (VMS), but one cohort study found no association. VMS may be triggered by declining estrogen levels during menopause, whereas elevated estrogen levels have been associated with increased breast cancer risk. VMS may thus be indicative of lower susceptibility to breast cancer. Methods: We evaluated this relationship in the longitudinal Study of Women’s Health Across the Nation (SWAN), using discrete survival analysis of approximately annual data on VMS and self-reported breast cancer occurrences for up to 13 years of follow-up in 3,098 women who were pre- or early perimenopausal at enrollment. Results: Over an average 11.4 years of follow-up, 129 incident breast cancer cases were self-reported, and approximately 50 % of participants experienced VMS. Symptomatic women had a reduced risk of breast cancer compared to non-symptomatic women (adjusted HR 0.63, 95 % CI 0.39, 1.00). The association was stronger in the subgroup of women who fully transitioned to postmenopause during follow-up (n = 67 cases, adjusted HR 0.45, 95 % CI 0.26, 0.77). Conclusion: VMS appeared to be a marker of reduced breast cancer risk. Future research is needed to understand the biology underlying this relationship.

AB - Purpose: Two case–control studies reported a 50 % decreased breast cancer risk among women who experienced menopausal vasomotor symptoms (VMS), but one cohort study found no association. VMS may be triggered by declining estrogen levels during menopause, whereas elevated estrogen levels have been associated with increased breast cancer risk. VMS may thus be indicative of lower susceptibility to breast cancer. Methods: We evaluated this relationship in the longitudinal Study of Women’s Health Across the Nation (SWAN), using discrete survival analysis of approximately annual data on VMS and self-reported breast cancer occurrences for up to 13 years of follow-up in 3,098 women who were pre- or early perimenopausal at enrollment. Results: Over an average 11.4 years of follow-up, 129 incident breast cancer cases were self-reported, and approximately 50 % of participants experienced VMS. Symptomatic women had a reduced risk of breast cancer compared to non-symptomatic women (adjusted HR 0.63, 95 % CI 0.39, 1.00). The association was stronger in the subgroup of women who fully transitioned to postmenopause during follow-up (n = 67 cases, adjusted HR 0.45, 95 % CI 0.26, 0.77). Conclusion: VMS appeared to be a marker of reduced breast cancer risk. Future research is needed to understand the biology underlying this relationship.

KW - Breast cancer

KW - Menopause

KW - Postmenopausal

KW - Vasomotor symptoms

UR - http://www.scopus.com/inward/record.url?scp=84988984761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988984761&partnerID=8YFLogxK

U2 - 10.1007/s10552-016-0811-9

DO - 10.1007/s10552-016-0811-9

M3 - Article

C2 - 27680016

AN - SCOPUS:84988984761

VL - 27

SP - 1333

EP - 1340

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 11

ER -